Full text 
Texts adopted
PDF 65kWORD 31k
Thursday, 13 September 2012 - Strasbourg
Tackling multiple sclerosis in Europe

Declaration of the European Parliament of 13 September 2012 on tackling multiple sclerosis in Europe

The European Parliament,

–  having regard to Rule 123 of its Rules of Procedure,

A.  whereas approximately 600 000 Europeans suffer from multiple sclerosis (MS), which is the most common neurodegenerative disorder and is a major cause of non-traumatic disability in young adults;

B.  whereas most people with MS are diagnosed in the prime of their working lives, and almost half leave the workforce within three years of diagnosis;

C.  whereas in Europe tremendous discrepancies in access to disease-modifying treatments and quality of care exist, and have worsened in recent months;

1.  Calls on the Commission and Council to:

   encourage, within the framework of Horizon 2020, closer scientific collaboration and comparative research on MS;
   promote, in their Reflection Process on Chronic Disease, equal access to treatment and flexible employment policies for people with chronic neurological disorders such as MS;

2.  Calls on the Member States to:

   enhance equal access to quality care, for example. by using certified educational training tools (such as ’MS Nurse Professional’) to develop, standardise and benchmark specialist nursing staff training;
   support the European Register for MS by encouraging patient data collection at national level;

3.  Instructs its President to forward this declaration, together with the names of the signatories(1), to the Council, the Commission and the Parliaments of the Member States.

(1) The list of signatories is published in Annex 1 to the Minutes of 13 September 2012 (P7_PV(2012)09-13(ANN1)).

Legal notice - Privacy policy